{"id":"NCT01259492","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD)","officialTitle":"A 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate HCl Extended Release in the Treatment of Adult Patients With Childhood-onset ADHD","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-11","primaryCompletion":"2012-08","completion":"2012-08","firstPosted":"2010-12-14","resultsPosted":"2014-04-29","lastUpdate":"2014-10-07"},"enrollment":725,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Attention Deficit/Hyperactivity Disorder"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Ritalin LA 20 mg","otherNames":[]},{"type":"DRUG","name":"Ritalin LA 30 mg","otherNames":[]}],"arms":[{"label":"Ritalin LA 40 mg","type":"EXPERIMENTAL"},{"label":"Ritalin LA 60 mg","type":"EXPERIMENTAL"},{"label":"Ritalin LA 80 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will evaluate efficacy and safety of methylphenidate hydrochloride extended release compared to placebo in adult patients with childhood-onset attention deficit/hyperactivity disorder (ADHD).","primaryOutcome":{"measure":"Change From Baseline of Period 1 (Baseline 1) to End of Period 1 on Attention-Deficit/Hyperactivity Disorder Rating Scale (DSM-IV ADHD RS) Total Score by Treatment","timeFrame":"Baseline 1 to End of Period 1 (Week 9)","effectByArm":[{"arm":"Ritalin LA 40 mg","deltaMin":16,"sd":12.18},{"arm":"Ritalin LA 60 mg","deltaMin":14.7,"sd":10.12},{"arm":"Ritalin LA 80 mg","deltaMin":16.8,"sd":11.36},{"arm":"Placebo","deltaMin":9.7,"sd":11.05}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":68,"countries":["United States","Belgium","Colombia","Denmark","Germany","Norway","Singapore","South Africa","Sweden"]},"refs":{"pmids":["24371021"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":695},"commonTop":["Headache","Decreased appetite","Dry mouth","Nasopharyngitis","Nausea"]}}